Completed PHASE1 INTERVENTIONAL NCT00001923

Transcranial Magnetic Stimulation for the Treatment of Phantom Pain

Phantom Pain: A Therapeutic Trial Using Transcranial Magnetic Stimulation

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Conditions Pain

Interventions Transcranial magnetic stimulation

Updated 5 times since 2017 Last updated: Mar 3, 2008 Started: Dec 31, 1998 Completion: Dec 31, 2002

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Pain and is currently completed. National Institute of Neurological Disorders and Stroke (NINDS) leads this study, which shows 5 recorded versions since 1998 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Dec 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Neurological Disorders and Stroke (NINDS)

Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bethesda, United States